F. Märki
Impact in
- Biochemistry top 1%
- Lipid metabolism and biosynthesis
- Eicosanoids and Hypertension Pharmacology
- Pharmacology top 2%
- Inflammatory mediators and NSAID effects
- Microbial Natural Products and Biosynthesis
Papers in
- Biochemistry 17
- Eicosanoids and Hypertension Pharmacology 10
- Lipid metabolism and biosynthesis 9
- Pharmacology 18
- Inflammatory mediators and NSAID effects 16
- Co-authors
- Josef M. Pfeilschifter (12 shared papers)Henk van den BOSCH (9 shared papers)Werner Pignat (10 shared papers)Klaus Vosbeck (4 shared papers)Josef Pfeilschifter (3 shared papers)Bernhard Witkop (2 shared papers)Richard Franson (1 shared paper)Caspar Schalkwijk (3 shared papers)
- Journals
- FEBS Letters (4 papers)Biochemical and Biophysical Research Communications (3 papers)Regulatory Peptides (3 papers)Biochemical Journal (2 papers)Hormone and Metabolic Research (2 papers)
- Partner nations
- SwitzerlandNetherlandsUnited States
In The Last Decade
F. Märki
45 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 86
- Biochemistry 371
- Pharmacology 475
- Microbiology 156
- Molecular Biology 538
- Nephrology 80
Countries citing papers authored by F. Märki
This map shows the geographic impact of F. Märki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by F. Märki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites F. Märki more than expected).
Fields of papers citing papers by F. Märki
This network shows the impact of papers produced by F. Märki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by F. Märki. The network helps show where F. Märki may publish in the future.
Co-authors
The 25 scholars most cited alongside F. Märki, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 46 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1989 | 176 | |
| 2 | 1991 | 115 | |
| 3 | 1991 | 98 | |
| 4 | 1986 | 95 | |
| 5 | 1990 | 93 | |
| 6 | 1992 | 84 | |
| 7 | 1963 | 77 | |
| 8 | 1990 | 74 | |
| 9 | 1992 | 71 | |
| 10 | 1987 | 56 | |
| 11 | 1991 | 52 | |
| 12 | 1991 | 48 | |
| 13 | Synovial type (group II) phospholipase A2 in cartilage. | 1993 | 46 |
| 14 | 1962 | 39 | |
| 15 | 1979 | 39 | |
| 16 | 1989 | 39 | |
| 17 | 1961 | 37 | |
| 18 | 1991 | 37 | |
| 19 | 1992 | 37 | |
| 20 | 1993 | 36 |
About F. Märki
F. Märki is a scholar working on Biochemistry, Pharmacology, Molecular Biology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 46 papers that have together received 1.6k indexed citations. Recurring topics across this work include Inflammatory mediators and NSAID effects (16 papers), Pancreatic function and diabetes (11 papers), Eicosanoids and Hypertension Pharmacology (10 papers), Protein Kinase Regulation and GTPase Signaling (10 papers), Lipid metabolism and biosynthesis (9 papers), Sphingolipid Metabolism and Signaling (5 papers), Chemical Synthesis and Analysis (3 papers) and Clinical Laboratory Practices and Quality Control (2 papers). The work is most often cited by research in Biochemistry (371 citations), Pharmacology (475 citations), Microbiology (156 citations), Molecular Biology (538 citations) and Nephrology (80 citations). F. Märki has collaborated with scholars based in Switzerland, Netherlands and United States. Frequent co-authors include Josef M. Pfeilschifter, Henk van den BOSCH, Werner Pignat, Klaus Vosbeck, Josef Pfeilschifter, Bernhard Witkop, Richard Franson, Caspar Schalkwijk, Andreas Fredenhagen and Casper G. Schalkwijk. Their work appears in journals such as FEBS Letters, Biochemical and Biophysical Research Communications, Regulatory Peptides, Biochemical Journal and Hormone and Metabolic Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.